ESTRO Guide 2018

Brachytherapy for Prostate Cancer 14-16 June 2018 | Avignon, France

TARGET GROUP The course is aimed at all those who may be part of a prostate brachytherapy team and for those wishing to set up a prostate brachytherapy unit i.e.: urologists, radiation oncologists, radiation therapists (RTTs) radiologists, physicists and specialist nurses. Learn about the ultimate high dose radiotherapy modality for prostate: fundamentals for the beginner and tips and tricks for those with experience. • Provide an overview of the epidemiology and treatment options for localised prostate cancer • Discuss patient selection, indications and contra- indications for brachytherapy • Provide anoverviewof the techniques, equipment and staffing for a prostate brachytherapy unit, including the physics background and regulatory requirements • Give an overview of the results, side effects and their management • Discuss new developments relevant to brachytherapy in imaging, focal therapy and salvage. COURSE AIM The course aims to:

SCHOOL

LEARNINGOUTCOMES By the end of this course participants should be able to understand the: • Requirements for a successful brachytherapy programme • Relevantpatientgroupsforprostatebrachytherapy and the literature reporting their outcome • Current areas of development in focal and salvage prostate brachytherapy. COURSE CONTENT This course covers an overview on epidemiology and treatment options for localised prostate cancer and gives an adequate introduction to brachytherapy. Patient selection for both HDR and LDR seed implants will be discussed with

treatment indications and contra-indications. Contouring for prostate brachytherapy with different imaging modalities is presented as an exercise prior to the course evaluated with interactive discussions. Practical examples of gland evaluation, types of treatment planning, different implant techniques and post implant planning are presented in the context of videos and interactive discussions between participants and the teaching staff. New approaches are discussed including salvage and focal therapy. Comparisons are presented between permanent (seed) and temporary (HDR) brachytherapy implants and between brachytherapy and other treatments available for prostate cancer.

60